Composition BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of BPC-157 and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of two co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation Lot-specific COA Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
GHK-Cu activating tumor suppressors while downregulating metastasis genes is the opposite of what most people assume
Key Takeaways Standard dose is 25 units (1mg): drawn from a vial reconstituted with 2.5mL of bacteriostatic water, using an insulin syringe
Treatment: There is no specific FDA-approved anti-viral therapy for measles, but general medical supervision and treatment can be helpful, according to the CDC
What ProHealth does offer transparent dosing, available COAs, arginate salt formulation, oral capsule convenience, and a long-standing industry track record represents quality indicators that consumers can evaluate alongside their own research and healthcare provider guidance
Thymosin Beta-4 itself is naturally present at high concentrations in platelets and at lower concentrations across many tissues
